Cardiovascular disease remains the leading cause of death worldwide, and among its most common manifestations are heart valve diseases that disrupt the delicate mechanics of blood flow. The heart valves—aortic, mitral, pulmonary, and tricuspid—must open and close with precise timing and sealing under constantly varying pressures and flow rates. When these valves become stenotic (narrowed) or regurgitant (leaky), the resulting disturbances in hemodynamics impose abnormal mechanical loads on cardiac tissues, accelerate disease progression, and compromise patient outcomes. Over the past two decades, computational simulation has emerged as a powerful tool to unravel the complex interaction between blood flow and valve mechanics. By combining patient-specific imaging with physics-based modeling, researchers can now visualize flow patterns, quantify forces on valve leaflets, and predict how interventions such as valve repair or replacement will alter the mechanical environment. This article provides a comprehensive overview of how blood flow simulation and mechanical force analysis are applied to understand, diagnose, and treat heart valve diseases.

Physiology of Heart Valves and Normal Hemodynamics

The heart operates as a dual pump, with each side (left and right) consisting of an atrium and a ventricle. The valves ensure unidirectional flow: the atrioventricular valves (mitral on the left, tricuspid on the right) prevent backflow into the atria during ventricular contraction, and the semilunar valves (aortic and pulmonary) prevent backflow into the ventricles during relaxation. In a healthy adult, the aortic valve opens when left ventricular pressure exceeds aortic pressure (around 80 mmHg during systole) and closes when the pressure reverses in diastole. The leaflets are thin, flexible structures composed of three layers—fibrosa, spongiosa, and ventricularis—each with distinct collagen and elastin organization that confer remarkable durability (over 3 billion cycles in a lifetime).

Normal blood flow through the aortic valve is laminar and characterized by relatively low shear stress (typically 10–30 dynes/cm² on the leaflet surfaces). Pressure gradients across the valve are minimal (less than 5 mmHg). The mitral valve, with its larger orifice and chordae tendineae, experiences different loading patterns: higher peak shear during rapid filling and significant tensile forces on the chordae during systole. Understanding these baseline conditions is essential because deviations caused by disease directly correlate with the magnitude and location of mechanical stress.

Mechanical Forces in Heart Valve Disease

Valvular pathology fundamentally alters the mechanical microenvironment. The three primary forces acting on valve tissue—shear stress, pressure, and tensile forces—become pathological in disease states, driving tissue remodeling, inflammation, and calcification.

Shear Stress

Shear stress arises from the frictional drag of blood flowing over the endothelial surfaces of the leaflets. In aortic stenosis, the narrowed orifice creates a high-velocity jet (up to 5 m/s compared to 1 m/s normal) that generates shear stresses exceeding 200 dynes/cm². This pathologically high shear can denude endothelial cells, expose subendothelial collagen, and promote platelet activation and aggregation. In regurgitant lesions, reverse flow produces turbulent eddies that impose oscillatory shear, which is even more damaging because it triggers pro-inflammatory endothelial phenotypes. Computational studies have shown that regions of low or oscillatory shear stress correlate with the sites of lipid deposition and calcific nodule formation.

Pressure

Transvalvular pressure gradients are a hallmark of valve disease. In severe aortic stenosis, the pressure drop across the valve can exceed 40 mmHg during systole, forcing the left ventricle to generate higher pressures to maintain cardiac output. This afterload increase leads to concentric hypertrophy, fibrosis, and eventually heart failure. In mitral regurgitation, systolic pressure in the left atrium rises to 30–40 mmHg (normal ~10 mmHg), leading to pulmonary congestion. Simulations can map these pressure distributions in three dimensions, revealing localized pressure hot spots on leaflets that are prone to tearing or prolapse.

Tensile Forces

Tensile forces act to stretch the valve tissue during opening and closing. In the mitral valve, the chordae tendineae experience peak tensions of approximately 10–15 N during systole in a healthy valve. In myxomatous degeneration (mitral valve prolapse), the chordae become elongated and weakened, leading to abnormal stress concentration at their insertion points. Finite element analyses have shown that chordal rupture often occurs when local tensile stress exceeds 20–25 N. Similarly, in bicuspid aortic valve disease, the asymmetric leaflets experience uneven tensile loading, driving accelerated calcification and fibrosis at the raphe.

Computational Modeling Techniques

Simulating blood flow and mechanical forces in heart valves requires a multi-physics approach. Two primary methods dominate the field: computational fluid dynamics (CFD) for fluid flow and finite element analysis (FEA) for solid mechanics. Coupled fluid–structure interaction (FSI) models integrate both to capture the mutual influence between deforming leaflets and flow fields.

Computational Fluid Dynamics (CFD)

CFD solves the Navier–Stokes equations for fluid motion within a defined domain. For heart valve simulations, the domain is typically derived from medical imaging (CT or MRI) of the patient’s anatomy. The steps are:

  1. Image segmentation: Semiautomated algorithms extract the lumen and valve geometry from volumetric scans. This produces a triangulated surface mesh.
  2. Mesh generation: The surface is filled with a volumetric mesh—typically tetrahedral or hexahedral elements. Boundary layer refinement is crucial near the leaflet walls to capture steep velocity gradients. Modern meshing tools (e.g., ANSYS ICEM, Star-CCM+, OpenFOAM) can produce meshes with 1–10 million elements.
  3. Boundary conditions: At the inlet (ventricle or atrium), physiologically realistic velocity or pressure waveforms are prescribed. Outlet conditions may include Windkessel models that mimic arterial compliance and resistance.
  4. Solution: The unsteady Navier–Stokes equations are solved using finite volume or finite element methods. Turbulence models (e.g., k-ω SST) are often required because stenotic flows become transitional or turbulent.
  5. Post-processing: Derived quantities include wall shear stress, pressure drop, kinetic energy, vorticity, and particle residence time.

CFD alone cannot capture leaflet motion unless the geometry is prescribed from cine imaging (e.g., from 4D CT). For fully coupled deformation, FSI is needed.

Finite Element Analysis (FEA) for Valve Tissues

FEA solves the equations of continuum mechanics for solid bodies. Valve leaflets are modeled as hyperelastic, nearly incompressible materials. The Ogden model or Fung-type exponential models are common. Key mechanical properties—stiffness, anisotropy, failure stress—are obtained from biaxial tension tests on excised tissue or from literature values. The FEA workflow:

  • Geometry: Same segmented leaflet surfaces as CFD, but now represented as thin shells or solid elements with thickness (typically 0.5–1.5 mm).
  • Material assignment: Fiber orientation (collagen fibers aligned circumferentially in the fibrosa) can be mapped onto the mesh using histological data or diffusion tensor imaging.
  • Loading conditions: Pressure loads from CFD or measured pressure traces are applied. Contact modeling prevents leaflets from interpenetrating during closure.
  • Solution: Implicit or explicit time integration schemes handle large deformations. Abaqus, LS-DYNA, and FEBio are widely used.
  • Output: Stress and strain distributions, tear risk, calcification propensity.

Fluid–Structure Interaction (FSI)

FSI couples CFD and FEA to allow bidirectional exchange of forces and displacements at the fluid–solid interface. Two main coupling strategies exist: monolithic (solving both simultaneously) and partitioned (iterating between separate solvers). The immersed boundary method is also popular, where the valve leaflets are represented as fiber networks within the fluid grid, eliminating the need for body-fitted meshes. FSI simulations are computationally intensive—often requiring thousands of CPU hours—but they provide the most physiologically realistic representation. Recent advances in GPU computing and reduced-order models (e.g., lumped-parameter networks) are making FSI more accessible for clinical applications.

Simulating Specific Valve Diseases

Aortic Stenosis

Aortic stenosis (AS) is the most common valve disease in the elderly. Calcific nodules form on the fibrosa side of the leaflets, restricting motion. CFD studies of AS consistently show a high-velocity eccentric jet distal to the valve, with regions of flow separation and recirculation in the sinuses of Valsalva. Wall shear stress on the aortic wall immediately downstream can reach 10 times normal, which has been implicated in post-stenotic dilation. FSI models reveal that the calcified leaflets experience not only higher peak stress but also altered fiber tension that can propagate tears. Simulation is used to predict the optimal valve area for transcatheter aortic valve replacement (TAVR), helping choose the prosthesis size that minimizes paravalvular leak and stress on the native annulus.

Mitral Regurgitation

Mitral regurgitation (MR) can result from annular dilation, leaflet prolapse, or chordal rupture (flail leaflet). CFD simulations of MR demonstrate a systolic regurgitant jet that impinges on the left atrial wall, causing high wall shear stress and risk of endothelial damage. The flow pattern is highly dependent on the regurgitant orifice shape and location. FEA models of the mitral valve apparatus—including leaflets, chordae, and papillary muscles—are used to simulate repair techniques such as annuloplasty ring implantation or chordal replacement. By comparing pre- and post-repair stress distributions, surgeons can evaluate which approach best restores normal leaflet coaptation and reduces residual leakage.

Bicuspid Aortic Valve

Bicuspid aortic valve (BAV) affects 1–2% of the population and is frequently associated with aortic root dilation. The abnormal leaflet geometry creates asymmetric flow patterns and elevated shear stress on the aortic wall, especially in the region of the right coronary sinus. Simulation studies have quantified this asymmetry, showing that the valve with a fused raphe produces a flow jet that targets the convexity of the ascending aorta, correlating with aortopathy. FSI models of BAV can predict which patients are at highest risk for rapid dilation and may guide timing of prophylactic aortic surgery.

Clinical Applications and Predictive Modeling

The ultimate goal of simulation is to improve patient care. Several clinical applications are already in use or under active development:

  • Pre-procedural planning for TAVR: CFD-based assessment of the native aortic valve geometry and calcification pattern helps predict paravalvular leak and coronary obstruction. Commercial software (e.g., HeartFlow, FEops) provides simulated transvalvular gradients and regurgitation volumes for different prosthesis sizes.
  • Mitral valve repair simulation: Surgeons use FEA to test different repair configurations (e.g., ring size, neochord placement) on a 3D-printed or virtual model of the patient’s valve. Studies show that simulation-guided repairs reduce the need for reoperation.
  • Prosthetic valve design: Companies like Edwards Lifesciences and Medtronic rely heavily on CFD and FEA to optimize leaflet geometry, frame stiffness, and anti-calcification treatments. Simulations accelerate the development cycle and reduce animal testing.
  • Risk stratification: For asymptomatic patients with severe AS, simulation can estimate the rate of calcification progression by linking regions of high mechanical stress to the probability of new nodule formation. This may eventually guide the timing of valve replacement.

A particularly promising area is the use of machine learning to expedite simulations. Neural networks trained on large datasets of CFD results can predict flow and stress distributions in milliseconds, enabling real-time feedback during catheter-based procedures. For example, researchers have developed surrogate models that predict wall shear stress from simple geometric parameters of the aortic valve, achieving accuracy within 5% of full CFD.

Future Directions

The field is moving toward personalized, multi-scale modeling. Current simulations typically resolve only the organ-scale hemodynamics, but valve disease involves processes at cellular and molecular levels. Multi-scale models that couple tissue-scale stress with cell signaling pathways (e.g., endothelial-to-mesenchymal transition in calcification) are being developed. These require integration of transcriptomic data and mechanotransduction models, a challenge that calls for collaboration between engineers, biologists, and clinicians.

Another frontier is the inclusion of cardiac mechanics beyond the valve. Whole-heart FSI models that incorporate ventricular contraction, fibrous architecture, and valve dynamics are becoming feasible thanks to exascale computing. Such models can capture the ventricular–valve interaction in diseases like functional mitral regurgitation (where the ventricle is dilated but the valve leaflets are structurally normal). Ultimately, a digital twin of the patient’s heart could be used to test multiple interventions virtually before selecting the optimal treatment.

Regulatory acceptance is also advancing. The U.S. Food and Drug Administration (FDA) has issued guidance on the use of simulation as valid scientific evidence for medical device approvals. In silico clinical trials (ISCT) are being proposed to supplement or replace traditional trials for certain indications, particularly for rare valve diseases where patient recruitment is difficult. The FDA guidance on reporting computational modeling studies outlines best practices for verification, validation, and uncertainty quantification.

Conclusion

Simulation of blood flow and mechanical forces has transformed our understanding of heart valve diseases. By combining high-resolution imaging, robust physics-based models, and growing computational power, researchers can now visualize the invisible forces that drive valve pathology. These tools are not just academic—they are already aiding clinical decisions, improving surgical outcomes, and guiding the design of next-generation prosthetic valves. As the field progresses toward personalized, multi-scale, and real-time simulations, the impact on cardiovascular medicine will only deepen. The challenge ahead lies in validating these models against long-term clinical outcomes and integrating them seamlessly into routine care. With continued interdisciplinary effort, simulation will become an indispensable pillar of valvular heart disease management.